In summary, this systematic review with meta-analysis summarized and evaluated the potential correlation of high NRP1 expression with worse prognosis and tumor-associated clinicopathological characteristics in CRC and liver cancer patients. The gene discussed is NRP1; the disease is colorectal carcinoma.